Michael S. Lawrence

188.7k total citations · 4 hit papers
88 papers, 11.3k citations indexed

About

Michael S. Lawrence is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael S. Lawrence has authored 88 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 37 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Michael S. Lawrence's work include Cancer Genomics and Diagnostics (34 papers), RNA modifications and cancer (14 papers) and Genomics and Chromatin Dynamics (13 papers). Michael S. Lawrence is often cited by papers focused on Cancer Genomics and Diagnostics (34 papers), RNA modifications and cancer (14 papers) and Genomics and Chromatin Dynamics (13 papers). Michael S. Lawrence collaborates with scholars based in United States, Germany and Spain. Michael S. Lawrence's co-authors include Gad Getz, Matthew Meyerson, Stacey Gabriel, Petar Stojanov, Eric S. Lander, Craig H. Mermel, Todd R. Golub, Levi A. Garraway, James Robinson and Gordon Saksena and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Michael S. Lawrence

82 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and saturation analysis of cancer genes across 21 tumour types

2014 2.1k citations Michael S. Lawrence, Levi A. Garraway et al. profile →
Pan-cancer patterns of somatic copy number alteration

2013 1.2k citations Michael S. Lawrence, Gad Getz et al. profile →
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

2013 832 citations Michael S. Lawrence, Gad Getz et al. profile →
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

2014 588 citations Michael S. Lawrence, Gad Getz et al. profile →

Peers

Countries citing papers authored by Michael S. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Michael S. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Lawrence more than expected).

Fields of papers citing papers by Michael S. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Lawrence. The network helps show where Michael S. Lawrence may publish in the future.

Co-authorship network of co-authors of Michael S. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Lawrence. A scholar is included among the top collaborators of Michael S. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Lawrence. Michael S. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus–associated oropharynx cancer early detection 2025 ·JNCI Journal of the National Cancer Institute ·(unknown), (unknown), (unknown), Michael Bryan, (unknown), (unknown), (unknown), (unknown), Adam S. Fisch, Zoe Guan, (unknown), Birgitta E. Michels, Tim Waterboer, Jeremy D. Richmon, Viktor A. Adalsteinsson, Michael S. Lawrence, Matthew G. Crowson, A. John Iafrate, Daniel L. Faden	0
2	APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability 2024 ·Science Advances ·Ajinkya S. Kawale, Xiaojuan Ran, Parasvi S. Patel, Sneha Saxena, Michael S. Lawrence, Lee Zou	21
3	Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations 2024 ·Nature Communications ·(unknown), Ramin Sakhtemani, (unknown), Michael S. Lawrence, Ashok S. Bhagwat	13
4	Chromatin-bound protein colocalization analysis using bedGraph2Cluster and PanChIP 2023 ·STAR Protocols ·(unknown), Ioannis Sanidas, Nicholas J. Dyson, Michael S. Lawrence	1
5	Patterns in the tapestry of chromatin-bound RB 2023 ·Trends in Cell Biology ·Ioannis Sanidas, Michael S. Lawrence, Nicholas J. Dyson	7
6	The RNA m5C modification in R-loops as an off switch of Alt-NHEJ 2023 ·Nature Communications ·Haibo Yang, (unknown), Xiaojuan Ran, (unknown), Parasvi S. Patel, Xueping Zhu, Yao Xiao, (unknown), (unknown), Lee Zou, Michael S. Lawrence, Li Lan	22
7	Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops 2022 ·Nucleic Acids Research ·Ramin Sakhtemani, (unknown), Daniel Hübschmann, Reiner Siebert, Michael S. Lawrence, Ashok S. Bhagwat	4
8	Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer 2022 ·Science Advances ·Marcello Stanzione, Jun Zhong, Edmond Wong, Thomas J. LaSalle, Jillian F. Wise, Antoine Simoneau, David T. Myers, Sarah Phat, Moshe Sade-Feldman, Michael S. Lawrence, M. Kyle Hadden, Lee Zou, Anna F. Farago, Nicholas J. Dyson, Benjamin J. Drapkin	22
9	Extracellular matrix proteins regulate NK cell function in peripheral tissues 2022 ·Science Advances ·Mark D. Bunting, (unknown), Marta Requesens, Adam Langenbucher, (unknown), Robert T. Manguso, Michael S. Lawrence, Shadmehr Demehri	38
10	RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer 2021 ·Clinical Cancer Research ·Siang‐Boon Koh, Kenneth N. Ross, Steven J. Isakoff, (unknown), Lei He, (unknown), Andrew Schultz, Erica L. Mayer, Tiffany A. Traina, Lisa A. Carey, Hope S. Rugo, Minetta C. Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S. Lawrence, Leif W. Ellisen	16
11	An extended APOBEC3A mutation signature in cancer 2021 ·Nature Communications ·Adam Langenbucher, (unknown), Ramin Sakhtemani, Elodie Bournique, Jillian F. Wise, Lee Zou, Ashok S. Bhagwat, Rémi Buisson, Michael S. Lawrence	68
12	Targeted degradation of the enhancer lysine acetyltransferases CBP and p300 2021 ·Cell chemical biology ·Raghu Vannam, (unknown), (unknown), (unknown), Eileen Hu, Johannes Kreuzer, Robert Morris, Xcanda Ixchel Herrera Lopez, (unknown), Wilhelm Haas, Michael S. Lawrence, Christopher J. Ott	102
13	Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots 2020 ·Nature Communications ·Pégah Jalili, (unknown), Adam Langenbucher, (unknown), Karmen Aguirre, Ryan B. Corcoran, Angela G. Fleischman, Michael S. Lawrence, Lee Zou, Rémi Buisson	70
14	Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers 2020 ·Science Advances ·Mihriban Karaayvaz, (unknown), Adam Langenbucher, Srinivas Vinod Saladi, Kenneth N. Ross, (unknown), Andrea Desmond, Murat Yıldırım, (unknown), Hiranmayi Ravichandran, (unknown), Michelle C. Specht, Sridhar Ramaswamy, Michael S. Lawrence, Angelika Amon, Leif W. Ellisen	26
15	Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features 2019 ·Science ·Rémi Buisson, Adam Langenbucher, (unknown), Eugene E. Kwan, Cyril H. Benes, Lee Zou, Michael S. Lawrence	181
16	Histone Lysine Methylation Dynamics Control EGFR DNA Copy-Number Amplification 2019 ·Cancer Discovery ·Thomas L. Clarke, Ran Tang, Damayanti Chakraborty, Capucine Van Rechem, Fei Ji, (unknown), Anqi Ma, H. Ümit Kanıskan, Jian Jin, Michael S. Lawrence, Ruslan I. Sadreyev, Johnathan R. Whetstine	39
17	Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing 2019 ·Journal of Biological Chemistry ·Ramin Sakhtemani, (unknown), Jessica Stewart, (unknown), Roger Piqué-Regi, Michael S. Lawrence, Ashok S. Bhagwat	16
18	APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition 2017 ·Cancer Research ·Rémi Buisson, Michael S. Lawrence, Cyril H. Benes, Lee Zou	95
19	Assessing the clinical utility of cancer genomic and proteomic data across tumor types 2014 ·Nature Biotechnology ·Yuan Yuan, Eliezer M. Van Allen, Larsson Omberg, Nikhil Wagle, Ali Amin‐Mansour, Artem Sokolov, (unknown), Yanxun Xu, Kenneth R. Hess, Lixia Diao, Leng Han, Xuelin Huang, Michael S. Lawrence, John N. Weinstein, Joshua M. Stuart, Gordon B. Mills, Levi A. Garraway, (unknown), Gad Getz, Han Liang	214
20	RGtk2: A Graphical User Interface Toolkit for R 2011 ·SHILAP Revista de lepidopterología ·Duncan Temple Lang, Michael S. Lawrence	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact